Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 17, 2021 - Issue 11
Submit an article Journal homepage
1,769
Views
13
CrossRef citations to date
0
Altmetric
Case Report

Pityriasis rosea after administration of Pfizer-BioNTech COVID-19 vaccine

Olivia G. Cohena Department of Dermatology, The University of Pennsylvania, Philadelphia, PA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7080-5937
ORCID Icon,
Ashley K. Clarka Department of Dermatology, The University of Pennsylvania, Philadelphia, PA, USA
,
Heather Milbara Department of Dermatology, The University of Pennsylvania, Philadelphia, PA, USA
&
Mordechai Tarlowb Advanced Dermatology & Skin Surgery, PC, Lakewood, NJ, USA
Pages 4097-4098 | Received 07 Jun 2021, Accepted 25 Jul 2021, Published online: 26 Aug 2021

References

  • Drago F, Ciccarese G, Rebora A, Broccolo F, Parodi A. Pityriasis Rosea: a comprehensive classification. Dermatology. 2016;232(4):431–37. doi:10.1159/000445375.
  • Watanabe T, Kawamura T, Jacob SE, Blauvelt A, Jacob SE, Orenstein JM, Black JB. Pityriasis rosea is associated with systemic active infection with both human herpesvirus-7 and human herpesvirus-6. J Invest Dermatol. 2002;119(4):793–97. doi:10.1046/j.1523-1747.2002.00200.x.
  • Brzezinski P, Chiriac A. Uncommon presentation of pityriasis rosea after yellow fever inoculation. JAMA Dermatol. 2014;150(9):1020–21. doi:10.1001/jamadermatol.2013.10505.
  • Chen J-F, Chiang C-P, Chen Y-F, Wang W-M. Pityriasis rosea following influenza (H1N1) vaccination. J Chin Med Assoc. 2011;74(6) :280–82. doi: 10.1016/j.jcma.2011.04.010.
  • Ang LPL, Yanqiong L, Wenfei L. Recurrent pityriasis rosea: a case report. Hum Vaccines Immunother. 2018;14(4):1024–26. doi:10.1080/21645515.2017.1409928.
  • Francesco Drago GC, Rebora A, Parodi A. Pityriasis rosea following human papillomavirus vaccination. Braz J Infect Dis. 2015;19(2):224–25. doi:10.1016/j.bjid.2014.10.006.
  • Dimitrios Papakostasa PGS, Papafragkakia D, Grigorakib E, Avgerinoua G, Antonioua C. An atypical case of pityriasis rosea gigantea after influenza vaccination. Case Rep Dermatol. 2014;6:119–23. doi:10.1159/000362640.
  • Veraldi S, Spigariolo CB. Pityriasis rosea and COVID-19. J Med Virol. 2021;93(7):4068. doi:10.1002/jmv.26679.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.